Contemporary Therapeutic Approaches Targeting Bone Complications in Prostate Cancer
- 1 December 2010
- journal article
- review article
- Published by Elsevier BV in Clinical Genitourinary Cancer
- Vol. 8 (1), 29-36
- https://doi.org/10.3816/cgc.2010.n.005
Abstract
No abstract availableThis publication has 62 references indexed in Scilit:
- Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate CancerJournal of Urology, 2010
- Application of a Fracture Risk Algorithm to Men Treated With Androgen Deprivation Therapy for Prostate CancerJournal of Urology, 2010
- Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trialsThe Lancet Oncology, 2009
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate CancerThe New England Journal of Medicine, 2009
- Metabolic Complications of Androgen Deprivation Therapy for Prostate CancerJournal of Urology, 2009
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast CancerThe New England Journal of Medicine, 2009
- Toremifene Increases Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: Interim Analysis of a Multicenter Phase 3 Clinical StudyJournal of Urology, 2008
- Biology of RANK, RANKL, and osteoprotegerinArthritis Research & Therapy, 2007
- Obesity and Sex Steroids during Gonadotropin-Releasing Hormone Agonist Treatment for Prostate CancerClinical Cancer Research, 2007
- Mechanisms of Bone MetastasisThe New England Journal of Medicine, 2004